Archives
-
TTP, m6A, and Schistosomiasis Liver Fibrosis
2026-10-03
A 2026 PLOS Pathogens study identifies tristetraprolin as an antifibrotic regulator in Schistosoma japonicum-associated liver disease. The work links TTP to SMAD2/3-dependent WTAP transcription, increased m6A modification, reduced TGF-β1 mRNA stability, and weaker hepatic stellate cell activation, while highlighting important limits on how far these findings can be generalized.
-
EZ Cap Cy5 Firefly Luciferase mRNA Assay Design
2026-10-02
Learn how EZ Cap Cy5 Firefly Luciferase mRNA separates delivery, intracellular trafficking, and functional translation in one experiment. This evidence-led guide combines dual-reporter biology with practical assay design informed by a 2025 mRNA-LNP transfection study.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-10-01
Track where an mRNA formulation goes with Cy5 while measuring what it produces through Firefly Luciferase. This dual-readout design separates delivery, intracellular trafficking, and translation performance in transfection optimization, formulation screening, and imaging workflows.
-
8-DY547-cGMP for CA2 Memory Research
2026-10-01
Explore how 8-DY547-cGMP can support mechanistic studies of cyclic GMP signaling alongside hippocampal CA2 perineuronal-net research. This article translates findings from a recent Alzheimer’s disease study into a careful, hypothesis-driven assay strategy.
-
Cdk5, AMPK, and Neuronal Ferroptosis After Stroke
2026-09-30
The reference study identifies a mechanistic connection between Cdk5 activity, AMPK signaling, inflammatory microglial polarization, and hippocampal neuron ferroptosis after ischemic injury. Its combined mouse and cell-model design suggests that Cdk5 inhibition and AMPK activation can reduce neuroinflammation and iron-dependent neuronal damage, while also highlighting the need for direct iron measurements in follow-up studies.
-
DAPI Solution for IDD Cell-State Mapping
2026-09-30
DAPI and 4',6-Diamidino-2-Phenylindole provide a high-contrast nuclear readout for intervertebral disc degeneration research. This guide shows how to integrate DAPI with apoptosis, viability, microscopy, and flow cytometry assays without mistaking nuclear morphology for a stand-alone mechanistic endpoint.
-
Fluconazole Workflows for Fungal Resistance Research
2026-09-29
Build more interpretable antifungal assays with Fluconazole by controlling solvent, exposure, endpoint selection, and strain context. The workflow connects target-level inhibition with biofilm tolerance, Candida infection models, and resistance benchmarking against emerging antifungal strategies.
-
CCK Interneurons, BLA Inhibition, and Anxiety
2026-09-29
This study identifies basolateral amygdala cholecystokinin-expressing interneurons as a circuit element that can suppress local excitation and reduce stress-induced anxiety-like behavior in mice. By combining cell-type-specific chemogenetics, optogenetics, electrophysiology, and inhibitory-plasticity induction, the work links both acute transmission and longer-lasting plasticity to behavioral regulation.
-
DNMT3B, Nanaomycin A, and NEPC Translation
2026-09-28
DNMT3B is emerging as a mechanistic bridge between androgen-deprivation pressure, stemness, and neuroendocrine prostate cancer. This article translates the anchor study into a practical research strategy for evaluating (S,S)-Nanaomycin A as a DNMT3B-focused perturbation tool while keeping model selection, pharmacodynamic readouts, and translational limitations in view.
-
D-Mannitol for Osmotic Regulation Research
2026-09-28
D-Mannitol is a water-soluble reagent for controlled osmotic regulation research, renal function studies, and investigation of diuretic mechanisms. Use it in research workflows rather than as a substitute for a validated clinical formulation, and prepare solutions for near-term use because long-term solution storage is not recommended.
-
Two Signals, One mRNA: A Better Delivery Readout
2026-09-27
A translational framework for separating mRNA uptake from protein expression, using dual-reporter design, controlled validation, and the delivery lessons of spleen-selective LNP research.
-
Nadolol and Disease-State PK: A Better Study Design
2026-09-26
Nadolol (SQ-11725) is a useful probe for separating beta-adrenergic pharmacology from transporter-sensitive drug disposition. This article connects its cardiovascular research applications to disease-state pharmacokinetic findings while clearly distinguishing transferable study-design lessons from evidence that applies only to other compounds.
-
Storage Optimization for LNP Self-Replicating RNA Vaccines
2026-09-25
Kim and colleagues compared storage conditions for lipid nanoparticles carrying alphavirus-derived self-replicating RNA and found that RNase-free PBS with 10% sucrose at −20 °C preserved vaccine activity for 30 days at a level equivalent to freshly prepared material. The study also reports retained bioactivity after lyophilization, while underscoring that storage performance must be evaluated in the context of the complete LNP–RNA formulation.
-
Gestational PS-NPs and Adult Male Reproductive Injury
2026-09-25
A 2026 study combines testicular transcriptomics, serum metabolomics, and reproductive pathology to propose a partial adverse outcome pathway linking gestational polystyrene nano-plastics exposure with reproductive impairment in adult male offspring. Its integrated model identifies candidate molecular events for follow-up, while leaving key causal steps and exposure details for further investigation.
-
Cy5 amine (non-sulfonated): Labeling Workflow
2026-09-24
Cy5 amine is a primary-amine cyanine dye for coupling to compatible activated labeling partners when a bright, red-emitting fluorophore is needed. Because non-sulfonated Cy5 amine is insoluble in water, dissolve it in an organic solvent before controlled transfer into a compatible reaction; it is not a direct aqueous-labeling reagent or a diagnostic product.